Researchers find molecular shift that stops stem cells in Drosophila from making tumors

December 7, 2015
With the enzyme Eyeless knocked out, cells over-proliferate (shown in green) in a fruit fly's larval brain during reactivated Notch signaling. Credit: University of Oregon

University of Oregon scientists studying neural stem cells in the fruit fly Drosophila have uncovered a molecular change experienced by stem cells as they age. During development of the central nervous system, a protein is expressed that blocks tumor formation.

The research, detailed in a paper placed online ahead of print in the journal Current Biology, focused on the larval stage of fruit fly development. This is when generate most of the neurons that form the adult's brain. While rapidly dividing to produce new cells, these stem cells rely on the signaling pathway of the Notch protein.

Previous research has shown that when Notch signaling runs smoothly, the stem cells make neurons that populate the adult central nervous system. With too much Notch, stem cells lose control and over-proliferate - forming large tumors. In humans, adult T-cell leukemia is tied to overactive Notch signaling.

"Stem cells have a really tough job, because they have to divide to make the millions of neurons in our brain," said co-author Chris Doe, a professor of biology and a Howard Hughes Medical Institute Investigator based at the UO. "If they don't divide enough, it results in microcephaly or other small brain diseases, but if they divide too much they make tumors. They have to stay right on that boundary of dividing to make neurons but not dividing excessively and forming a tumor. It's really walking a tightrope."

University of Oregon doctoral student Dylan Farnsworth led a study that explored an important signaling pathway in stem cells involved in building the brains of fruit flies. He discovered age-related molecular changes that someday may help provide targets and improve the timing of stem cell therapies. Credit: Photo by Jim Barlow

In the new research, UO doctoral student Dylan Farnsworth discovered that if he waited for stem cells to divide a few times and age a bit, they quit responding to Notch. At this point, stem cells cannot be pushed by high doses of Notch signaling to form tumors. He wondered why.

Further study led to the discovery of age-related molecular changes. Late in their lives, and at about the same time they resist tumor formation, stem cells begin expressing a transcription factor protein, known as Eyeless in Drosophila and Pax6 in humans. Its presence blocks Notch signaling, Farnsworth said.

When Eyeless is knocked out in these stem cells, the researchers showed, Notch signaling overwhelms the balance again and forms brain tumors.

"If we can identify the stem cells that are relied upon during development, maybe we could find a way to use them later to re-create conditions that might be therapeutic," Farnsworth said. "If you do it incorrectly, you risk over-proliferation and the development of masses—and cancer."

Finding this role for Eyeless is a step in that direction, but it's possible that other molecules also are present and may also inhibit tumor growth, Doe said. "This paper shows that Eyeless is important for winding down the lifespan of the stem cells that are giving rise to the adult brain. It's a stop signal that says it is time to cease responding to Notch signals."

While the system used to probe these cells was created for basic science research in Doe's lab, it opens a new window to identify cells involved in the origin of cancers. In this case, tumors induced by Notch signaling in older stem cells were distinct from their earlier versions. Eventually, with more extensive research, the system could provide a roadmap to fine-tuning the timing of stem cell-based therapies to restart healthy activity in , Doe said.

Explore further: Signaling pathway suppresses brain tumors

More information: Dylan R. Farnsworth et al. Aging Neural Progenitors Lose Competence to Respond to Mitogenic Notch Signaling, Current Biology (2015). DOI: 10.1016/j.cub.2015.10.027

Related Stories

Signaling pathway suppresses brain tumors

December 4, 2015

Researchers at the University of Basel took a close look at a signaling pathway present in most organisms and found that it suppresses the formation of specific types of brain tumor. Their results have been published by the ...

A Prkci gene keeps stem cells in check

October 31, 2015

When it comes to stem cells, too much of a good thing isn't wonderful: producing too many new stem cells may lead to cancer; producing too few inhibits the repair and maintenance of the body.

A step forward in obtaining blood stem cells in laboratory

October 14, 2015

An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein ...

When is a stem cell not really a stem cell?

August 26, 2007

Working with embryonic mouse brains, a team of Johns Hopkins scientists seems to have discovered an almost-too-easy way to distinguish between “true” neural stem cells and similar, but less potent versions. Their finding, ...

Recommended for you

Tiny protein coiled coils that self-assemble into cages

October 17, 2017

(Phys.org)—A large team of researchers with members from Slovenia, the U.K, Serbia, France and Spain has developed a technique that causes proteins to self-assemble into geometric shapes on demand. In their paper published ...

The importance of asymmetry in bacteria

October 17, 2017

New research published in Nature Microbiology has highlighted a protein that functions as a membrane vacuum cleaner and which could be a potential new target for antibiotics.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.